Treatment of Myositis with IVIG in Baltimore, MD
Myositis is an inflammatory muscle disease that causes weakness, pain, and swelling. It can result from autoimmune disorders, infections, or injuries and requires careful management. Intravenous immunoglobulin (IVIG) is a specialized treatment that can alleviate symptoms by infusing healthy antibodies from donated blood, helping to modulate the immune system and improve muscle strength. At Jean Walter Infusion Center, Dr. Nasseri, MD, and his experienced team provide IVIG treatment tailored to each patient’s needs, ensuring accessibility and ongoing support throughout the process. For more information, please contact us or book an appointment online now! We are conveniently located at 724 Maiden Choice Lane, Baltimore, MD 21228.


Table of Contents:
How does IVIG work in treating myositis?
Who is a candidate for IVIG therapy for myositis?
How effective is IVIG in treating myositis symptoms?
How often do patients need IVIG infusions for myositis?
Myositis is characterized by inflammation and muscle weakness and encompasses disorders such as polymyositis and dermatomyositis, where the immune system erroneously targets muscle fibers. One of the key treatments we offer at our center is Intravenous Immunoglobulin (IVIG) therapy, which plays a crucial role in managing these conditions.
IVIG therapy involves the infusion of pooled immunoglobulins, or antibodies, sourced from the plasma of thousands of healthy donors. This treatment provides a broad spectrum of antibody activity and is known for its powerful immunomodulatory effects in patients with myositis. By introducing a high concentration of normal antibodies into the bloodstream, IVIG can help regulate the immune system’s activity and mitigate the autoimmune attack on muscle tissues.
At the Jean Walter Infusion Center, we ensure that our patients receive comprehensive care during their IVIG treatment. Our team of healthcare professionals closely monitors the infusion process to manage and minimize any potential side effects, such as headaches, fever, or infusion reactions, ensuring a safe and comfortable experience.
IVIG’s mechanisms of action include neutralizing harmful autoantibodies, inhibiting the activation of the complement system, and blocking Fc receptors on immune cells to prevent inflammation. Additionally, IVIG can modulate cytokine production, promoting a more balanced immune response by increasing anti-inflammatory cytokines while decreasing pro-inflammatory ones.
Patients receiving IVIG therapy at our center often experience significant improvements in muscle strength and a reduction in inflammation, enhancing their quality of life. While individual responses to IVIG may vary, it is typically considered when other treatments, like corticosteroids and immunosuppressants, are insufficient or not well-tolerated.
At the Jean Walter Infusion Center, we offer specialized Intravenous Immunoglobulin (IVIG) therapy as part of our comprehensive care approach for patients with myositis, a group of inflammatory muscle diseases. Our team is dedicated to providing personalized treatment plans for individuals who have not responded adequately to first-line treatments such as corticosteroids and immunosuppressive agents.
Our infusion center is equipped to support patients with dermatomyositis, characterized by distinctive skin rashes and muscle weakness. We understand that when skin manifestations are severe or resistant to other treatments, IVIG therapy can be an effective option. Our experienced medical staff closely monitors each patient’s progress to ensure optimal outcomes.
For patients with inclusion body myositis, primarily affecting older adults, we offer tailored IVIG therapy, recognizing that responses can vary. Our goal is to manage symptoms effectively, especially for those experiencing rapidly progressive muscle weakness or seeking to minimize the side effects associated with long-term steroid use.
We also consider IVIG therapy for patients with myositis who face additional challenges such as severe dysphagia or respiratory muscle involvement.
Our healthcare providers conduct thorough evaluations of each patient’s condition, medical history, and previous treatment responses to make informed decisions about initiating IVIG therapy. We are committed to delivering compassionate and individualized care to improve the quality of life for our patients with myositis.
IVIG therapy has become a vital option for patients suffering from myositis, a group of inflammatory muscle diseases, especially when traditional treatments such as corticosteroids and immunosuppressants have not yielded the desired results.
Our center understands the unique needs of myositis patients and offers IVIG therapy as a tailored approach to help manage their symptoms. IVIG works by modulating the immune system, introducing a diverse range of antibodies that can neutralize harmful autoantibodies and inhibit inflammatory pathways responsible for muscle damage. This can lead to a reduction in muscle inflammation and weakness, improving overall muscle strength and function—key goals for our patients.
Clinical studies and patient experiences have shown that IVIG can significantly enhance muscle strength and function, allowing patients to regain their ability to perform daily activities. At the Jean Walter Infusion Center, we often incorporate IVIG as part of a comprehensive treatment strategy, maximizing its effectiveness when used in combination with other therapies.
While IVIG is generally well-tolerated, we prioritize patient safety by closely monitoring for potential side effects such as headaches, fever, and allergic reactions. We also address the financial considerations of IVIG therapy, guiding patients through insurance and financial assistance options to make this valuable treatment accessible.
Understanding that each patient’s needs are unique, we begin with an initial series of IVIG infusions over two to five consecutive days to ensure optimal immunoglobulin levels. After this induction phase, we typically schedule maintenance infusions every three to four weeks. However, recognizing the variability in patient responses and the severity of conditions, some individuals may require adjustments, such as more frequent infusions every two weeks.
At the Jean Walter Infusion Center, we prioritize ongoing monitoring and personalized care. Our healthcare providers closely observe each patient’s clinical response to treatment, adjusting schedules as necessary to ensure the best outcomes. We strive to maintain open communication with our patients, encouraging regular follow-ups to evaluate the efficacy of treatment and make any needed modifications to the infusion regimen.
Our goal is to offer compassionate, individualized care, ensuring that each patient’s treatment plan aligns with their specific health needs and response to therapy. Trust the Jean Walter Infusion Center for expert management of IVIG therapy for myositis, with a commitment to improving your overall health and well-being. For more information, please contact us or book an appointment online now! We are conveniently located at 724 Maiden Choice Lane, Baltimore, MD 21228. We serve patients from Baltimore MD, Halethrope MD, Ferndale MD, Dundalk MD, Yorktown MD, and surrounding areas.